sulforaphane has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, the disease progression remains unaffected, because of continuous dopaminergic neuron loss." | 1.37 | Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. ( Cuadrado, A; Fernández-Ruiz, J; Hesse, M; Innamorato, NG; Jazwa, A; Rojo, AI, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jazwa, A | 1 |
| Rojo, AI | 1 |
| Innamorato, NG | 1 |
| Hesse, M | 1 |
| Fernández-Ruiz, J | 1 |
| Cuadrado, A | 1 |
1 other study available for sulforaphane and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anticarcinogenic Agents; Antioxidants; Basal | 2011 |